Mykinac

   
Google
 
Web NewDrugInformation.com

Mykinac


Drug - Mykinac
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Nystatin
Multiple ingredients are in alphabetical order.

Strength - 100,000 UNITS/GM
The potency of the active ingredient(s), Nystatin. May repeat for multiple part products.

Applicant - ALPHARMA US PHARMS
The firm name holding legal responsibility for Mykinac. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062731
The FDA assigned number to Mykinac. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Mykinac. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 22, 1986
The date Mykinac was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mykinac. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Mykinac is in. Format is RX, OTC, DISCN.

Applicant Full Name - Alpharma Us Pharmaceuticals Division
The full name of the firm holding legal responsibility for the new application of Mykinac.

Mykinac